Hope For Multiple Sclerosis: New Therapeutic Agent ST266 Shows Potential
As the efforts to eradicate the chronic condition caused by Multiple sclerosis continuously takes place after another, a new therapeutic agent has recently been tested in a mouse model of multiple sclerosis (MS). Consequently, the said experiment has been noted to have produced anti-inflammatory activity and prevented loss of cells in the optic nerve. It was found that the research has been conducted in the laboratory of Kenneth Shindler, MD, PhD, an associate professor of Ophthalmology and Neurology and the results have been published in the journal Scientific Reports.
New Therapeutic Agent Shows Potential As Multiple Sclerosis Cure
In one of their statements reported by News Medical Life Sciences, the researchers from the Perelman School of Medicine at the University of Pennsylvania, with Pittsburgh-based Noveome Biotherapeutics has allegedly discovered that there is a therapeutic potential of the agent, called ST266, for treating optic neuritis, inflammation that damages the optic nerve which is also a common presenting feature of MS. Furthermore, during their study, it turns out that nearly half of patients who were diagnosed with MS experience optic neuritis. The condition was also believed to have the ability to cause mild to moderate permanent loss of vision, but rarely complete blindness.
ST266 And Its Features
Meanwhile, as per News Wise, ST266 is known to be a solution of molecules that apparently stimulates paracrine signaling. It was found that through the said solution, it has become a means in which cells can communicate to each other: One cell is known to have the ability in producing a chemical signal that induces changes in nearby cells.
Ultimately, since the solution has been applied to mice, Shindler said that ST266's ability to preserve vision in the preclinical model and reduce neuronal loss would be a huge advance if it translates to human patients in the future. Additionally, the study findings suggest that ST266 helps promote optic neuron survival by potentially activating multiple pathways, including those that prevent cell death.
Update On Zika: WHO To Launch Strongest Zika Vaccine But After 2020;
As Zika becomes a globally epidemic disease, have we reached the success in our fight against the virus? What’s the truth behind the claims regarding the possible alleged strongest Zika vaccine set to be released after 2020? Is there a particular cause for the delay? Here’s what authorities have to say
Cancer Wonder Drug Finally Invented? UK Patient Claims Total Remission From Cancer
As the number of cancer cases continuously rise, is there still hope for humanity to find the cure to one of the deadliest disease, to date? What’s the truth behind claims regarding the discovery of an alleged wonder drug for cancer that is believed to have caused the total remission of a cancer patient? Here are the details
Breakthrough Study On Biotin Offers Probable Cure For Multiple Sclerosis; Is There A Catch?
Considering that there is no globally recognized cure to multiple sclerosis, can Biotin be considered as the ultimate game changer? What’s the truth behind claims that the breakthrough study on Biotin benefits has been acknowledged as ‘clinically relevant’ in the fight against the auto-immune disease? Is this the cure that we have been waiting? Here are the details
Elon Musk Is Working On A Consensual Telepathy; Latest Details Inside
Elon Musk has confirmed that Neuralink is real and that he is serious about the technology. The firm will soon develop a “neural lace” technology that would involve implanting tiny brain electrodes.
The Controversial ‘Liberation Therapy’: Is It Good For Multiple Sclerosis?
With the number of advancements that has been intended for Multiple Sclerosis, why is the so-called ‘Liberation Therapy’ found to ineffective? What makes the said therapy to be considered as a failure when it comes to treating the auto-immune disease? Could it mean that it’s now a hopeless case for one of the world’s most dreaded diseases? Here’s what experts have to say
Multiple Sclerosis May Now Be Predicted Through Fatigue And Leg Dysfunction, Experts Say
Considering that the emergence of Multiple Sclerosis is still being considered as mysterious, are there ways to predict if a person is at risk of developing the said auto-immune disease? What’s the truth behind claims that Fatigue and Leg Dysfunction may be used as onset identifiers of the disease? Find out what health experts have to say
MORE IN ITECHPOST
Tips for Speeding up a VPN
VPN is all about data and information security. It bars predators from snooping into your data. It prevents hackers from stealing confidential information. But wait, did you know that VPN can slow down your internet? Yes, it can.
How Do Personal Emergency Response Systems Work?
Personal emergency response systems, known as PERS for short, are systems that help people to raise the alarm and get immediate help when a medical or personal emergency occurs. They are ideal for older people and anyone with a mobility issue or an injury or illness that can cause falls.
How to Download Free Android Emulator for Gaming on PC?
Are you looking to play Android games on PC with the help of the best Android emulator? There are numerous types of online platform which provide user friendly access and support for the interested communities to get immediate access to install their best recommended Android applications.
Netflix is Raising Prices, Here’s How it Now Compares to Other Streaming Services
Once a brand gains the trust and loyalty of its market, it is only logical that it attempts to flex its dominant muscle. Such is the tale that fits the recent price hike coming from the stable of Netflix. Having baited consumers into believing that streaming, and not cable subscription, is the right way to go, Netflix has now decided to drop its own form of a bombshell on consumers in the form of price increment. The news, which was announced earlier this year, detailed that Netflix would be raising prices across all of its plans by 13 to 18 percent.